Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Stassen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Radiation Biology|August 29, 2003
Radiation-induced gene expression in MCF-7 cellsT Stassen, M Port, I Nuyken, et al.
Schweizer Archiv Fur Tierheilkunde|May 8, 2009
[Treatment of a uterine adenocarcinoma in a miniature pig by ovariohysterectomy]A-K Preissel, N Brugger, T Stassen, et al.
Journal of Applied Physiology|January 1, 1975
Additive effects of acetylcholine released by vagal nerve stimulation on atrial rateL M Hondeghem, E Mouton, T Stassen, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1992
Comparative copper coil-induced thrombogenicity of the internal mammary, left anterior descending coronary, and popliteal arteries in dogsH J Rapold, T Stassen, F Van de Werf, et al.
Blood|October 15, 1990
Comparison of intravenous bolus injection or continuous infusion of recombinant single chain urokinase-type plasminogen activator (saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosisH J Rapold, Z M Wu, T Stassen, et al.
Journal of Cardiovascular Pharmacology|August 1, 1990
Pharmacokinetics and coronary thrombolytic properties of two human tissue-type plasminogen activator variants lacking the finger-like, growth factor-like, and first kringle domains (amino acids 6-173) in a canine modelZ Wu, F Van de Werf, T Stassen, et al.
Circulation|July 15, 1997
Infarct size, myocardial hemorrhage, and recovery of function after mechanical versus pharmacological reperfusion: effects of lytic state and occlusion timeS V Pislaru, L Barrios, T Stassen, et al.
Thrombosis and Haemostasis|July 10, 1998
Comparison of a synthetic antithrombin III-binding pentasaccharide and standard heparin as an adjunct to coronary thrombolysisS V Pislaru, C Pislaru, X Zhu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Radiation Biology|August 29, 2003
Radiation-induced gene expression in MCF-7 cellsT Stassen, M Port, I Nuyken, et al.
Schweizer Archiv Fur Tierheilkunde|May 8, 2009
[Treatment of a uterine adenocarcinoma in a miniature pig by ovariohysterectomy]A-K Preissel, N Brugger, T Stassen, et al.
Journal of Applied Physiology|January 1, 1975
Additive effects of acetylcholine released by vagal nerve stimulation on atrial rateL M Hondeghem, E Mouton, T Stassen, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1992
Comparative copper coil-induced thrombogenicity of the internal mammary, left anterior descending coronary, and popliteal arteries in dogsH J Rapold, T Stassen, F Van de Werf, et al.
Blood|October 15, 1990
Comparison of intravenous bolus injection or continuous infusion of recombinant single chain urokinase-type plasminogen activator (saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosisH J Rapold, Z M Wu, T Stassen, et al.
Journal of Cardiovascular Pharmacology|August 1, 1990
Pharmacokinetics and coronary thrombolytic properties of two human tissue-type plasminogen activator variants lacking the finger-like, growth factor-like, and first kringle domains (amino acids 6-173) in a canine modelZ Wu, F Van de Werf, T Stassen, et al.
Circulation|July 15, 1997
Infarct size, myocardial hemorrhage, and recovery of function after mechanical versus pharmacological reperfusion: effects of lytic state and occlusion timeS V Pislaru, L Barrios, T Stassen, et al.
Thrombosis and Haemostasis|July 10, 1998
Comparison of a synthetic antithrombin III-binding pentasaccharide and standard heparin as an adjunct to coronary thrombolysisS V Pislaru, C Pislaru, X Zhu, et al.
Pageof 1